MedTrace Logo

Creating Live Interactions to Mitigate Barriers

NCT03317769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2019-07-23

No results posted yet for this study

Summary

This study is a validation study to evaluate the acceptability, feasibility and impact of a mobile psychosocial intervention to enhance social functioning in people with schizophrenia.

Conditions

Interventions

OTHER

Computerized Plasticity-Based Adaptive Cognitive Training

Training on computerized exercises that targets social cognition for 2 hours per week.

OTHER

Commercially available computerized training

Training on computerized, casual video games for 2 hours per week.

OTHER

Optimized social skills training

Group-video calls with Specialist for 1 hour per week where participants can interact with Specialist individually or as a group. Specialist will provide guidance, support and feedback, and send links and articles about information and topics discussed during the video calls.

OTHER

Unstructured support group sessions

Unstructured support group-video calls for 1 hour per week. The Specialist will not engage with participants (eg. providing participants with links to articles and additional support) or provide guidance for the group discussion.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Posit Science Corporation

    lead INDUSTRY

Principal Investigators

  • Bruno Biagianti, MD, PhD · Posit Science Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-05-31
Completion
2019-06-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317769 on ClinicalTrials.gov